Agilent 400-DS Manuals

The Varian 400-DS Dissolution Apparatus sets the performance standard for drug-release testing of medical devices. It is the first dissolution apparatus built specifically for small-volume dissolution testing of combination drug products that meets all compendial requirements for USP Apparatus VII. The 400-DS provides compliance with 21 CFR Part 11 guidelines and brings an unprecedented level of convenience, throughput and efficiency to your quality control and R&D operations.

This document describes the innovative features of Agilent 400-DS Dissolution Apparatus 7, including automation and integration for small-volume dissolution testing. It is suitable for testing combinatorial drug products such as drug eluting stents, extractables and leachables, and other extended-release pharmaceutical products.